Cost-Effective Analysis of Diarrhea Therapy for Inpatients at Putri Hijau Hospital, Medan
DOI:
https://doi.org/10.52622/jisk.v3i1.46Keywords:
Diarrhea, cost effectiveness analysis, retrospectiveAbstract
Diarrhea is characterized by the excretion of liquid stools with a frequency of three or more times a day, due to gastrointestinal infections due to food and water contaminated with microorganisms, or directly from humans due to poor sanitation. This study was to determine the characteristics of diarrhea patients, treatment and cost-effectiveness of treatment at Putri Hijau Hospital, Medan. The non-experimental research is descriptive and retrospective in nature of financial patient medical records from July to December 2018. Cost Effectiveness Analysis as a method of cost analysis. The characteristics of the patients obtained were 14 women (46.670%) and 16 men (53.33%). The effectiveness of New Diatabs (92.30%) and New Diatabs Metronidazole (94.11%). The cost of therapy with New Diatabs is Rp. 1,547,771/patient and New Diatabs Metronidazole is Rp. 1,562,590/patient. Average cost-effectiveness New Diatabs Rp. 190,345 and New Diatabs Metronidazole Rp. 183,060, so it is concluded that the cost-effective therapy is the use of the combination of New Diatabs Metronidazole compared to New Diatabs.
Downloads
References
Widjaja MC. Mengatasi Diare & Keracunan pada Balita. Jakarta: Kawan Pustaka; 2009.
Anita A, Syamsul D, Suprianto S. Evaluasi Pemakaian Antibiotik yang Rasional pada ISPA Non Pneumonia di Puskesmas Induk Kota Binjai. J Dunia Farm. 2019;3(3):106–14. https://doi.org/10.33085/jdf.v3i3.4481
Faridah N, Machlaurin A, Subagio PB. Analisis Efektivitas Biaya Penggunaan Antibiotik terhadap Pasien Sepsis Pediatrik di Rawat Inap RSD dr. Soebandi Kabupaten Jember pada Tahun 2014 Pustaka Kesehat. 2016;4(2):255–62.
Budiharto M, Kosen S. Peranan Farmako-Ekonomi dalam Sistem Pelayanan Kesehatan Di Indonesia. Bul Penelit Sist Kesehat. 2008;11(4):337–40. https://doi.org/10.22435/bpsk.v11i4
Musdalipah M, Setiawan MA, Santi E. Analisis Efektivitas Biaya Antibiotik Sefotaxime dan Gentamisin Penderita Pneumonia pada Balita di RSUD Kabupaten Bombana Provinsi Sulawesi Tenggara. J Ilm Ibnu Sina. 2018;3(1):1–11. https://doi.org/10.36387/jiis.v3i1.104
Lubis MA, Suprianto S. Analisis Cost-Effectivenees penggunaan Antidiabetik Oral pada Pasien Diabetes Melitus Tipe 2 Rawat Jalan Peserta Bpjs di Rsu Haji Medan. J Dunia Farm. 2018;2(3):128–47. https://doi.org/10.33085/jdf.v2i3.4406 Abdulah R, Siregar RF, Alfian SD. Analisis Efektivitas Biaya Penggunaan Kombinasi Antipsikotik pada Pasien Rawat Inap Skizofrenia. Indones J Clin Pharm. 2017;6(1):61–6.
Ahmad A, Patel I, Parimilakrishnan S, Mohanta GP, Chung H, Chang J. The Role of Pharmacoeconomics in Current Indian Healthcare System. J Res Pharm Pract. 2013;2(1):3–9. https://doi.org/10.4103/2279-042x.114081
Sari FM, Suprianto. Tingkat Kepuasan Pasien terhadap Pelayanan Kefarmasian di Apotek Global Medan. J Dunia Farm. 2017;1(3):91–100. https://doi.org/10.33085/jdf.v1i3.4371
Korompis F, Tjitrosantoso H, Goenawi LR. Studi Penggunaan Obat pada Penderita Diare Akut di Instalasi Rawat Inap Blu RSUP Prof. Dr. RD Kandou Manado Periode Januari–Juni 2012. Pharmacon. 2013;2(1):42–51.
Wahyuni H, Diana VE, Suprianto S. Rasionalitas Penggunaan dan Kelengkapan Resep Non Steroid Anti Inflamasi Drugs (NSAID) pada Tiga Puskesmas di Kabupaten Gayo Lues. J Dunia Farm. 2019;3(2):69–78. https://doi.org/10.33085/jdf.v3i2.4471
Rizwani W, Suprianto S. Penggunaan Obat Anti Tuberkulosis di Puskesmas Kota Juang Kabupaten Bireuen Aceh. J Dunia Farm. 2017;1(2):70–3. https://doi.org/10.33085/jdf.v1i2.4359
Indonesia IA. ISO: Informasi Spesialite Obat Indonesia. Vol. 51. Jakarta: Ikatan Apoteker Indonesia; 2019.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Jurnal Indah Sains dan Klinis
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This work is licensed under a 
